- Home
- ADRX vs MLCO Comparison
ADRX vs MLCO Comparison
Compare ADRX & MLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADRX | MLCO |
|---|---|---|
| Founded | 2019 | 2003 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.6B |
| IPO Year | 2026 | 2006 |
Fundamental Metrics
Financial Performance| Metric | ADRX | MLCO |
|---|---|---|
| Price | $14.58 | $4.26 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 13 |
| Target Price | ★ $34.25 | $5.59 |
| AVG Volume (30 Days) | 396.7K | ★ 2.2M |
| Earning Date | 11-12-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $89.41 | N/A |
| Revenue Next Year | $510.33 | $7.64 |
| P/E Ratio | ★ N/A | $12.16 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.50 | $3.67 |
| 52 Week High | $19.57 | $9.53 |
Technical Indicators
Market Signals| Indicator | ADRX | MLCO |
|---|---|---|
| Relative Strength Index (RSI) | 39.02 | 49.18 |
| Support Level | $12.50 | $4.07 |
| Resistance Level | $18.94 | $4.86 |
| Average True Range (ATR) | 1.59 | 0.18 |
| MACD | -0.16 | 0.04 |
| Stochastic Oscillator | 30.24 | 51.74 |
Price Performance
Historical ComparisonAbout ADRX ADARx Pharmaceuticals Inc. Common Stock
Adarx Pharmaceuticals Inc is a late-clinical stage biotechnology company focused on developing next-generation siRNA therapeutics designed to treat a broad spectrum of diseases. Its pipeline includes three clinical-stage programs and two advanced preclinical programs. The three hepatic-targeted programs are agazisiran, onvuzosiran, and ADX-626, while the two extrahepatic-targeted programs are ADX-077 and ADX-199.
About MLCO Melco Resorts & Entertainment Limited
Melco Resorts & Entertainment is one of only six licensed casino operators in Macao. It operates Altira, a complex focused on premium customers; City of Dreams, an integrated resort in Cotai serving both mass-market and premium patrons; and Mocha Clubs' electronic gaming machines. The company also has a majority interest in Studio City, which opened in 2015. Outside Macao, Melco owns City of Dreams Manila in the Philippines and City of Dreams Mediterranean in Cyprus. The business mix in terms of adjusted EBITDA was about 84% from Macao, with the rest from overseas as of 2025.